Zuwei Li
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Ferroptosis and cancer prognosis
Papers in ⓘ
-
- Circular RNAs in diseases 9
- RNA modifications and cancer 3
-
- Ferroptosis and cancer prognosis 9
- Renal cell carcinoma treatment 6
- Co-authors
- Ying Chen (1 shared paper)Xiang Pan (12 shared papers)Liwen Zhao (11 shared papers)Yongqing Lai (13 shared papers)Jing Quan (10 shared papers)Hao Liang (2 shared papers)Yaxian Li (1 shared paper)Xiaoling Li (1 shared paper)
- Journals
- Biomedicine & Pharmacotherapy (3 papers)Life Sciences (3 papers)IEICE Transactions on Electronics (2 papers)Frontiers in Cardiovascular Medicine (2 papers)Cell Death Discovery (1 paper)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Zuwei Li
46 papers receiving 935 citations
Peers
Comparison fields: 5 of 103
- Cancer Research 391
- Pulmonary and Respiratory Medicine 304
- Molecular Biology 489
- Oncology 153
- Immunology 97
Countries citing papers authored by Zuwei Li
This map shows the geographic impact of Zuwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zuwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zuwei Li more than expected).
Fields of papers citing papers by Zuwei Li
This network shows the impact of papers produced by Zuwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zuwei Li. The network helps show where Zuwei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Zuwei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 156 | |
| 2 | 2018 | 108 | |
| 3 | 2020 | 71 | |
| 4 | 2010 | 43 | |
| 5 | 2020 | 43 | |
| 6 | 2021 | 42 | |
| 7 | 2021 | 40 | |
| 8 | 2020 | 37 | |
| 9 | 2018 | 34 | |
| 10 | 2020 | 33 | |
| 11 | 2020 | 28 | |
| 12 | 2018 | 24 | |
| 13 | 2020 | 21 | |
| 14 | 2023 | 18 | |
| 15 | MiR-378a-5p acts as a tumor suppressor in renal cell carcinoma and is associated with the good prognosis of patients. | 2019 | 18 |
| 16 | 2018 | 18 | |
| 17 | 2018 | 16 | |
| 18 | 2018 | 16 | |
| 19 | 2014 | 16 | |
| 20 | 2018 | 15 |
About Zuwei Li
Zuwei Li is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Cancer Research, Electrical and Electronic Engineering and Surgery, having authored 48 papers that have together received 940 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), MicroRNA in disease regulation (10 papers), Circular RNAs in diseases (9 papers), Ferroptosis and cancer prognosis (9 papers), Renal cell carcinoma treatment (6 papers), Magnetic properties of thin films (4 papers), Cancer Immunotherapy and Biomarkers (3 papers) and RNA modifications and cancer (3 papers). The work is most often cited by research in Cancer Research (391 citations), Pulmonary and Respiratory Medicine (304 citations), Molecular Biology (489 citations), Oncology (153 citations) and Immunology (97 citations). Zuwei Li has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Ying Chen, Xiang Pan, Liwen Zhao, Yongqing Lai, Jing Quan, Hao Liang, Yaxian Li, Xiaoling Li, Michael Nardi and Wenjuan Zhang. Their work appears in journals such as Biomedicine & Pharmacotherapy, Life Sciences, IEICE Transactions on Electronics, Frontiers in Cardiovascular Medicine and Cell Death Discovery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.